Seher Yıldız Tacar

3PUBLICATIONS
18CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 22, 2021
Thirty-day mortality rates after immunotherapy initiation.

Osman Sütcüoğlu, Ayşegül İlhan, Seher Yıldız Tacar

|Apr 14, 2021
Crizotinib for c-MET-amplified advanced NSCLC: a single-center experience.

Seher Yildiz Tacar, Mesut Yilmaz, Buge Oz

|Apr 13, 2021
Ribociclib induced acute kidney injury: A case report.

Ilkay Gulturk, Mesut Yilmaz, Aykut Ozmen

Pageof 1